Showing 1 - 2 of 2 results
Status:
Other
Class (Stereo):
CHEMICAL (ACHIRAL)
KU-0063794 was originally developed as part of the Kudos Biochemical experimental program, Pfizer in 2009 bought Kudos Biochemicals for its pipeline portfolio; KU has not been clinically developed since then. KU-0063794 is a highly specific inhibitor...
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Tranilast is an antiallergic drug developed by Kissei Pharmaceuticals. It was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993. It has been used for the treatment ...